397 related articles for article (PubMed ID: 12042646)
1. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
Joya-Vazquez PP; Dodson FS; Dvorchik I; Gray E; Chesky A; Demetris AJ; Shakil O; Fung JJ; Vargas HE
Transplantation; 2002 May; 73(10):1598-602. PubMed ID: 12042646
[TBL] [Abstract][Full Text] [Related]
2. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
Wong TC; Fung JY; Cui TY; Lam AH; Dai JW; Chan AC; Cheung TT; Chok KS; Ng KK; Lo CM
J Hepatol; 2019 Jun; 70(6):1114-1122. PubMed ID: 30871981
[TBL] [Abstract][Full Text] [Related]
4. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
[TBL] [Abstract][Full Text] [Related]
6. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
Holt D; Thomas R; Van Thiel D; Brems JJ
Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
Loss GE; Mason AL; Blazek J; Dick D; Lipscomb J; Guo L; Perrillo RP; Eason JD
Clin Transplant; 2001; 15 Suppl 6():55-8. PubMed ID: 11903388
[TBL] [Abstract][Full Text] [Related]
8. Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
Brandl A; Stolzlechner P; Eschertzhuber S; Aigner F; Weiss S; Vogel W; Krannich A; Neururer S; Pratschke J; Graziadei I; Öllinger R
Transpl Int; 2016 Apr; 29(4):471-82. PubMed ID: 26716608
[TBL] [Abstract][Full Text] [Related]
9. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Cholongitas E; Papatheodoridis GV; Burroughs AK
J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
[TBL] [Abstract][Full Text] [Related]
10. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
14. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Chen YS; Wang CC; de Villa VH; Wang SH; Cheng YF; Huang TL; Jawan B; Chiu KW; Chen CL
Clin Transplant; 2002 Dec; 16(6):405-9. PubMed ID: 12437618
[TBL] [Abstract][Full Text] [Related]
15. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
[TBL] [Abstract][Full Text] [Related]
16. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
17. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
[TBL] [Abstract][Full Text] [Related]
18. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
[TBL] [Abstract][Full Text] [Related]
19. Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?
Loss GE; Mason AL; Nair S; Blazek J; Farr G; Guo L; Cohen AJ; Eason JD
Liver Transpl; 2003 Dec; 9(12):1258-64. PubMed ID: 14625825
[TBL] [Abstract][Full Text] [Related]
20. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
Cholongitas E; Goulis I; Antoniadis N; Fouzas I; Imvrios G; Giakoustidis D; Giouleme O; Papanikolaou V; Akriviadis E; Vasiliadis T
Transpl Infect Dis; 2016 Oct; 18(5):667-673. PubMed ID: 27421122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]